ERK1/2 inhibitor 10
ERK1/2 inhibitor 10 (Compound 36c) is a potent ERK1 and ERK2 inhibitor (IC50: 0.11 and 0.08 nM respectively) . ERK1/2 inhibitor 10 inhibits ERK1/2 and blocks the phosphorylation expression of their downstream substrates p90RSK and c-Myc. ERK1/2 inhibitor 10 induces cell apoptosis and incomplete autophagy-related cell death. ERK1/2 inhibitor 10 shows potent antitumor efficacy against triple-negative breast cancer and colorectal cancer models harboring BRAF and RAS mutations[1].
Product Specifications
CAS Number
[3056077-07-4]
UNSPSC
12352005
Target
ERK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/erk1-2-inhibitor-10.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC(C2=NC(NC3=CC=NC(C)=C3)=NC=C2Cl)=CS1)N[C@@H](C4=CC=CC=C4)CO
Molecular Formula
C23H20ClN5O2S
Molecular Weight
465.96
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ERK1; ERK2
Explore Other Products
Browse additional items from our catalog
RET (CDHF12, CDHR16, PTC, RET51, Proto-oncogene Tyrosine-protein Kinase Receptor Ret, Cadherin Family Member 12, Proto-oncogene c-Ret, Soluble RET Kinase Fragment, Extracellular Cell-membrane Anchored RET Cadherin 120kD Fragment) (MaxLight 490)
